2021 Online, In the cloud

I-62 Silvia Grandoni
Therapeutic effect of anti-IL6 monoclonal antibodies in the treatment of COVID-19 in adults and multisystem inflammatory syndrome in children using siltuximab as a case study
I-63 Charlotte Kern
Modeling changes in SARS-CoV-2 variants within-host transmissibility on antiviral drug effect
I-64 Timothy Knab
A Physiologically-based Pharmacokinetic Modeling Approach to Support Candidate and First in Human Dose Selection for Bamlanivimab
I-65 Tarunendu Mapder
Antiviral Treatment on SARS-Cov-2 Infected Epithelial Tissue Patch
I-66 Aurélien MARC
Developing a model of SARS-CoV-2 viral dynamics under monoclonal antibody treatment.
I-67 Dirk Jan Moes
Towards fixed dosing of tocilizumab in ICU admitted COVID-19 patients; results of an observational population pharmacokinetic and descriptive pharmacodynamic study
I-68 Venkatesh Pilla Reddy
Application of modelling and simulation in development of an antibody cocktail for the prevention and treatment of COVID-19